Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas G Martin

Showing results (81-90 of 133) with videos related to

Pageof 14
Sort By:
Cells|March 29, 2023
BAG3: Nature's Quintessential Multi-Functional Protein Functions as a Ubiquitous Intra-Cellular GlueCaitlyn M Brenner, Muaaz Choudhary, Michael G McCormick, et al.
Hematological Oncology|June 2, 2022
Isatuximab plus carfilzomib and dexamethasone versus carfilzomib and dexamethasone in elderly patients with relapsed multiple myeloma: IKEMA subgroup analysisThierry Facon, Philippe Moreau, Thomas G Martin, et al.
Journal of Geriatric Oncology|October 16, 2020
Serial comprehensive geriatric and quality of life assessments in adults age ≥ 50 years undergoing autologous hematopoietic cell transplantationMariam T Nawas, Ying Sheng, Chiung-Yu Huang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 8, 2019
Functional Status as Measured by Geriatric Assessment Predicts Inferior Survival in Older Allogeneic Hematopoietic Cell Transplantation RecipientsLi-Wen Huang, Ying Sheng, Charalambos Andreadis, et al.
Journal of Geriatric Oncology|September 7, 2023
Association of geriatric measures and global frailty with cognitive decline after allogeneic hematopoietic cell transplantation in older adultsLi-Wen Huang, Ying Shi, Charalambos Andreadis, et al.
JCI Insight|October 19, 2018
Diabetes with heart failure increases methylglyoxal modifications in the sarcomere, which inhibit functionMaria Papadaki, Ronald J Holewinski, Samantha Beck Previs, et al.
Journal of Geriatric Oncology|June 5, 2014
Hematopoietic cell transplantation comorbidity index (HCT-CI) is predictive of adverse events and overall survival in older allogeneic transplant recipientsJesse W Keller, Charalambos Andreadis, Lloyd E Damon, et al.
Blood|March 3, 2016
Randomized multicenter phase 2 study of pomalidomide, cyclophosphamide, and dexamethasone in relapsed refractory myelomaRachid C Baz, Thomas G Martin, Hui-Yi Lin, et al.
Leukemia & Lymphoma|May 7, 2025
Single-center experience with nelarabine, etoposide, and cyclophosphamide in adults with relapsed/refractory T-acute lymphoblastic leukemia/lymphomaTamer Othman, Mimi M Lo, Charalambos B Andreadis, et al.
Leukemia|September 16, 2022
Ixazomib, lenalidomide and dexamethasone consolidation with randomized ixazomib or lenalidomide maintenance after autologous transplant in newly diagnosed multiple myelomaMichael Slade, Thomas G Martin, Nitya Nathwani, et al.
Pageof 14

Showing results (81-90 of 133) with videos related to

Sort By:
Pageof 14
Cells|March 29, 2023
BAG3: Nature's Quintessential Multi-Functional Protein Functions as a Ubiquitous Intra-Cellular GlueCaitlyn M Brenner, Muaaz Choudhary, Michael G McCormick, et al.
Hematological Oncology|June 2, 2022
Isatuximab plus carfilzomib and dexamethasone versus carfilzomib and dexamethasone in elderly patients with relapsed multiple myeloma: IKEMA subgroup analysisThierry Facon, Philippe Moreau, Thomas G Martin, et al.
Journal of Geriatric Oncology|October 16, 2020
Serial comprehensive geriatric and quality of life assessments in adults age ≥ 50 years undergoing autologous hematopoietic cell transplantationMariam T Nawas, Ying Sheng, Chiung-Yu Huang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 8, 2019
Functional Status as Measured by Geriatric Assessment Predicts Inferior Survival in Older Allogeneic Hematopoietic Cell Transplantation RecipientsLi-Wen Huang, Ying Sheng, Charalambos Andreadis, et al.
Journal of Geriatric Oncology|September 7, 2023
Association of geriatric measures and global frailty with cognitive decline after allogeneic hematopoietic cell transplantation in older adultsLi-Wen Huang, Ying Shi, Charalambos Andreadis, et al.
JCI Insight|October 19, 2018
Diabetes with heart failure increases methylglyoxal modifications in the sarcomere, which inhibit functionMaria Papadaki, Ronald J Holewinski, Samantha Beck Previs, et al.
Journal of Geriatric Oncology|June 5, 2014
Hematopoietic cell transplantation comorbidity index (HCT-CI) is predictive of adverse events and overall survival in older allogeneic transplant recipientsJesse W Keller, Charalambos Andreadis, Lloyd E Damon, et al.
Blood|March 3, 2016
Randomized multicenter phase 2 study of pomalidomide, cyclophosphamide, and dexamethasone in relapsed refractory myelomaRachid C Baz, Thomas G Martin, Hui-Yi Lin, et al.
Leukemia & Lymphoma|May 7, 2025
Single-center experience with nelarabine, etoposide, and cyclophosphamide in adults with relapsed/refractory T-acute lymphoblastic leukemia/lymphomaTamer Othman, Mimi M Lo, Charalambos B Andreadis, et al.
Leukemia|September 16, 2022
Ixazomib, lenalidomide and dexamethasone consolidation with randomized ixazomib or lenalidomide maintenance after autologous transplant in newly diagnosed multiple myelomaMichael Slade, Thomas G Martin, Nitya Nathwani, et al.
Pageof 14